Humasis Co. Ltd. (KOSDAQ:205470)
South Korea · Delayed Price · Currency is KRW 4,005.00
-70.00 (-1.72%)
Apr 15, 2026, 8:37 AM KST
Humasis Market Cap
Humasis has a market cap or net worth of 90.64 billion as of April 29, 2026. Its market cap has decreased by -50.86% in one year.
Market Cap
90.64B
Enterprise Value
-82.24B
Revenue
30.11B
Ranking
n/a
PE Ratio
n/a
Stock Price
4,005.00
Market Cap Chart
Since September 27, 2017, Humasis's market cap has increased from 10.76B to 90.64B, an increase of 742.09%. That is a compound annual growth rate of 28.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 13, 2026 | 90.64B | -21.01% |
| Dec 30, 2025 | 114.74B | -38.06% |
| Dec 30, 2024 | 185.23B | -22.80% |
| Dec 28, 2023 | 239.92B | -47.44% |
| Dec 29, 2022 | 456.45B | -20.07% |
| Dec 30, 2021 | 571.04B | 75.79% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 27, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 69.85T |
| Celltrion | 43.39T |
| ALTEOGEN | 20.15T |
| Samsung Epis Holdings | 14.08T |
| IMB Dx | 101.21B |
| Kukje Pharma | 96.72B |
| Cellid, | 91.16B |
| GeneOne Life Science | 88.23B |